AI Article Synopsis

  • Cancer cell growth and resistance pose significant challenges in liver cancer treatment, necessitating reliable models for predictive medicine.
  • The study utilized multi-omic screening and machine learning to create the mitochondrial cell death index (MCDI), which integrates data to forecast patient outcomes and treatment responses.
  • Findings highlight nine key genes linked to liver cancer prognosis, with PAK1IP1 emerging as a crucial predictor, suggesting that MCDI could improve personalized treatment approaches for patients.

Article Abstract

Background: Cancer cell growth, metastasis, and drug resistance are major challenges in treating liver hepatocellular carcinoma (LIHC). However, the lack of comprehensive and reliable models hamper the effectiveness of the predictive, preventive, and personalized medicine (PPPM/3PM) strategy in managing LIHC.

Methods: Leveraging seven distinct patterns of mitochondrial cell death (MCD), we conducted a multi-omic screening of MCD-related genes. A novel machine learning framework was developed, integrating 10 machine learning algorithms with 67 different combinations to establish a consensus mitochondrial cell death index (MCDI). This index underwent rigorous evaluation across training, validation, and in-house clinical cohorts. A comprehensive multi-omics analysis encompassing bulk, single-cell, and spatial transcriptomics was employed to achieve a deeper insight into the constructed signature. The response of risk subgroups to immunotherapy and targeted therapy was evaluated and validated. RT-qPCR, western blotting, and immunohistochemical staining were utilized for findings validation.

Results: Nine critical differentially expressed MCD-related genes were identified in LIHC. A consensus MCDI was constructed based on a 67-combination machine learning computational framework, demonstrating outstanding performance in predicting prognosis and clinical translation. MCDI correlated with immune infiltration, Tumor Immune Dysfunction and Exclusion (TIDE) score and sorafenib sensitivity. Findings were validated experimentally. Moreover, we identified PAK1IP1 as the most important gene for predicting LIHC prognosis and validated its potential as an indicator of prognosis and sorafenib response in our in-house clinical cohorts.

Conclusion: This study developed a novel predictive model for LIHC, namely MCDI. Incorporating MCDI into the PPPM framework will enhance clinical decision-making processes and optimize individualized treatment strategies for LIHC patients.

Supplementary Information: The online version contains supplementary material available at 10.1007/s13167-024-00362-8.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11147991PMC
http://dx.doi.org/10.1007/s13167-024-00362-8DOI Listing

Publication Analysis

Top Keywords

cell death
12
machine learning
12
hepatocellular carcinoma
8
mitochondrial cell
8
mcd-related genes
8
in-house clinical
8
lihc
5
mcdi
5
multi-omic profiling
4
profiling reveals
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!